Antigen kinetics determines immune reactivity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 13, 2008, Pages 5189-5194

  Johansen, Pål ^a   Storni, Tazio ^a   Rettig, Lorna ^a   Qiu, Zhiyong ^b   Der Sarkissian, Ani ^b   Smith, Kent A ^b   Manolova, Vania ^c   Lang, Karl S ^d   Senti, Gabriela ^a,e   Müllhaupt, Beat ^e   Gerlach, Tilman ^e   Speck, Roberto F ^e   Bot, Adrian ^b   Kündig, Thomas M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b MannKind Corporation   (United States)

^c CYTOS BIOTECHNOLOGY AG   (Switzerland)

^d INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Antigen presentation; Antiviral immunity; CD8 T cell responses; Tumor vaccine

Indexed keywords

INTERLEUKIN 2; ANTIGEN; VIRUS VACCINE;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOREACTIVITY; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNOLOGY; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; DRUG SCREENING; IMMUNOLOGY; KINETICS; LYMPHOCYTE; METABOLISM;

MUS;

ANIMALS; ANTIGENS; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; INTERLEUKIN-2; KINETICS; LYMPHOCYTES; MICE; MICE, INBRED C57BL; VIRAL VACCINES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 42449141017     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0706296105     Document Type: Article

References (50)

1. Janeway CA, Jr (1989) Cold Spring Harb Symp Quant Biol 54:1-13.
2. Zinkernagel RM (1996) Science 271:173-178.
3. Germain RN (2004) Nat Med 10:1307-1320.
4. O'Hagan DT, Valiante NM (2003) Nat Rev Drug Discov 2:727-735.
5. Johansen P, Senti G, Martinez Gomez JM, Storni T, von Beust BR, Wuthrich B, Bot A, Kundig TM (2005) Clin Exp Allergy 35:1591-1598.
6. Falo LD, Jr, Colarusso LJ, Benacerraf B, Rock KL (1992) Proc Natl Acad Sci USA 89:8347-8350.
7. Widmann C, Maryanski JL, Romero P, Corradin G (1991) J Immunol 147:3745-3751.
8. Johansen P, Stamou P, Tascon RE, Lowrie DB, Stockinger B (2004) Eur J Immunol 34:91-97.
9. Shedlock DJ, Shen H (2003) Science 300:337-339.
10. Sun JC, Bevan MJ (2003) Science 300:339-342.
11. Kaech SM, Wherry EJ, Ahmed R (2002) Nat Rev Immunol 2:251-262.
12. Binder D, Kundig TM (1991) J Immunol 146:4301-4307.
13. Schwartz RH (1992) Cell 71:1065-1068.
14. Huppa JB, Gleimer M, Sumen C, Davis MM (2003) Nat Immunol 4:749-755.
15. Gray D (2002) Nat Rev Immunol 2:60-65.
16. Iezzi G, Karjalainen K, Lanzavecchia A (1998) Immunity 8:89-95.
17. Rachmilewitz J, Lanzavecchia A (2002) Trends Immunol 23:592-595.
18. van Stipdonk MJ, Lemmens EE, Schoenberger SP (2001) Nat Immunol 2:423-429.
19. Malek TR, Bayer AL (2004) Nat Rev Immunol 4:665-674.
20. D'Souza WN, Schluns KS, Masopust D, Lefrancois L (2002) J Immunol 168:5566-5572.
21. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Annu Rev Immunol 19:683-765.
22. Bousso P, Robey E (2003) Nat Immunol 4:579-585.
23. Mitchison NA (1964) Proc R Soc London B Biol Sci 161:275-292.
24. Weigle WO (1973) Adv Immunol 16:61-122.
25. Nossal GJ (1983) Annu Rev Immunol 1:33-62.
26. Zinkernagel RM (2000) Semin Immunol 12:163-171.
27. Zinkernagel RM, Hengartner H (2001) Science 293:251-253.
28. Bachmann MF, Rohrer UH, Kundig TM, Burki K, Hengartner H, Zinkernagel RM (1993) Science 262:1448-1451.
29. Storni T, Kundig TM, Senti G, Johansen P (2005) Adv Drug Deliv Rev 57:333-355.
30. Nossal G (1999) in Fundamental Immunology, ed Paul WE (Lippincot-Raven, Philadelphia), pp 1387-1425.
31. Lofthouse S (2002) Adv Drug Deliv Rev 54:863-870.
32. Ehrenhofer C, Opdebeeck JP (1995) Vet Parasitol 59:263-273.
33. Guery JC, Galbiati F, Smiroldo S, Adorini L (1996) J Exp Med 183:485-497.
34. Zhu G, Mallery SR, Schwendeman SP (2000) Nat Biotechnol 18:52-57.
35. Borbulevych OY, Baxter TK, Yu Z, Restifo NP, Baker BM (2005) J Immunol 174:4812-4820.
36. Levitsky V, Zhang QJ, Levitskaya J, Masucci MG (1996) J Exp Med 183:915-926.
37. Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EM, Held G, Dunbar PR, Esnouf RM, Sami M, et al. (2005) J Exp Med 201:1243-1255.
38. Rivoltini L, Squarcina P, Loftus DJ, Castelli C, Tarsini P, Mazzocchi A, Rini F, Viggiano V, Belli F, Parmiani G (1999) Cancer Res 59:301-306.
39. Brinckerhoff LH, Kalashnikov VV, Thompson LW, Yamshchikov GV, Pierce RA, Galavotti HS, Engelhard VH, Slingluff CL, Jr (1999) Int J Cancer 83:326-334.
40. Ayyoub M, Mazarguil H, Monsarrat B, Van den Eynde B, Gairin JE (1999) J Biol Chem 274:10227-10234.
41. Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel RM (1989) Nature 342:559-561.
42. Pascolo S, Bervas N, Ure JM, Smith AG, Lemonnier FA, Perarnau B (1997) J Exp Med 185:2043-2051.
43. Battegay M, Cooper S, Althage A, Banziger J, Hengartner H, Zinkernagel RM (1991) J Virol Methods 33:191-198.
44. Bachmann MF, Kundig TM, Freer G, Li Y, Kang CY, Bishop DH, Hengartner H, Zinkernagel RM (1994) Eur J Immunol 24:2228-2236.
45. Kundig TM, Castelmur I, Bachmann MF, Abraham D, Binder D, Hengartner H, Zinkernagel RM (1993) J Virol 67:3680-3683.
46. Schwarz K, Storni T, Manolova V, Didierlaurent A, Sirard JC, Rothlisberger P, Bachmann MF (2003) Eur J Immunol 33:1465-1470.
47. Krieg AM (2002) Annu Rev Immunol 20:709-760.
48. Farman CA, Kornbrust DJ (2003) Toxicol Pathol 31(Suppl):119-122.
49. Mutwiri GK, Nichani AK, Babiuk S, Babiuk LA (2004) J Control Release 97:1-17.
50. Kundig TM, Bachmann MF, Lefrancois L, Puddington L, Hengartner H, Zinkernagel RM (1993) J Immunol 150:4450-4456.